• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.23% Nasdaq Up1.74%

    More On MBI.V



    News & Info


    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Med BioGene Inc. (MBI.V)

    0.05 0.00(0.00%) Oct 1
    ProfileGet Profile for:
    Med BioGene Inc.
    598 East Kent Avenue South
    Vancouver, BC V5X 4V6
    Canada - Map
    Phone: 604-732-8821
    Fax: 604-732-4801
    Website: http://www.medbiogene.com

    Index Membership:N/A
    Industry:Medical Laboratories & Research
    Full Time Employees:N/A

    Business Summary 

    Med BioGene Inc., a life science company, focuses on managing the license and rights to the genomic-based clinical laboratory diagnostic tests. Its products include the GeneFx Lung, a gene expression-based test for early-stage non-small-cell lung cancer that analyzes the molecular profile of a patientÂ’s tumor to provide information to assist in tailoring treatment for that specific patient. The company has a collaboration agreement with the University Health Network. Med BioGene Inc. was founded in 2002 and is headquartered in Vancouver, Canada.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Med BioGene Inc.

    Key Executives 
    Mr. Iain Weir-Jones ,
    Chairman and Chief Exec. Officer
    Ibrahim Ghobrial ,
    Chief Financial Officer
    Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in CAD.